복수 및 자발세균복막염

키워드

참고문헌 (82)

1. Gines P, "Compensated cirrhosis: natural history and prognostic factors", Hepatology, 7, pp.122~128 (1987)
2. Gines P, "Management of cirrhosis and ascites", N Engl J Med, 350, pp.1646~1654 (2004)
3. Planas R, "Natural history of patients hospitalized for management of cirrhotic ascites", Clin Gastroenterol Hepatol, 4, pp.1385~1394 (2006)
4. Schrier RW, "Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis", Hepatology, 8, pp.1151~1157 (1988)
5. Martin PY, "Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis", N Engl J Med, 339, pp.533~541 (1998)
6. Saadeh S, "Management of ascites in patients with end-stage liver disease", Rev Gastroenterol Disord, 4, pp.175~185 (2004)
7. Heneghan MA, "Pathogenesis of ascites in cirrhosis and portal hypertension", Med Sci Monit, 6, pp.807~816 (2000)
8. Runyon BA, "The serum-ascites albumin gradient is superior to the exudate-transudate concept in the differential diagnosis of ascites", Ann Intern Med, 117, pp.215~220 (1992)
9. Moore KP, "Guidelines on the management of ascites in cirrhosis", Gut, 55, pp.1~12 (2006)
10. Cattau EL, Jr, "Castell DO. The accuracy of the physical examination in the diagnosis of suspected ascites", JAMA, 247, pp.1164~1166 (1982)
11. Kuiper JJ, "Review article: Management of ascites and associated complications in patients with cirrhosis", Aliment Pharmacol Ther, 26(2), pp.183~193 (2007)
12. Gines P, "The management of ascites and hyponatremia in cirrhosis", Semin Liver Dis, 28, pp.43~58 (2008)
13. Caly WR, "A prospective study of bacterial infections in patients with cirrhosis", J Hepatol, 18, pp.353~358 (1993)
14. Rimola A, "Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club", J Hepatol, 32, pp.142~153 (2000)
15. Runyon BA, "Management of adult patients with ascites due to cirrhosis", Hepatology, 39, pp.841~856 (2004)
16. Bar-Meir S, "Analysis of ascitic fluid in cirrhosis", Dig Dis Sci, 24, pp.136~144 (1979)
17. Akriviadis EA, "Utility of an algorithm in differentiating spontaneous from secondary bacterial peritonitis", Gastroenterology, 98, pp.127~133 (1990)
18. Runyon BA, "Optimization of ascitic fluid culture technique", Gastroenterology, 95, pp.1351~1355 (1988)
19. Runyon BA, "Bedside inoculation of blood culture bottles with ascitic fluid is superior to delayed inoculation in the detection of spontaneous bacterial peritonitis", J Clin Microbiol, 28, pp.2811~2812 (1990)
20. Moore KP, "The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club", Hepatology, 38, pp.258~266 (2003)
21. Hepatic cirrhosis, "Diseases of the liver and biliary system. 11th ed.", pp.365~380 (2002), Blackwell Science
22. Llach J, "Prognostic value of arterial pressure, endogenous vasoactive systems, and renal function in cirrhotic patients admitted to the hospital for the treatment of ascites", Gastroenterology, 94, pp.482~487 (1988)
23. D'Amico G, "Survival and prognostic indicators in compensated and decompensated cirrhosis", Dig Dis Sci, 31, pp.468~475 (1986)
24. Bernardi M, "Efficacy and safety of the stepped care medical treatment of ascites in liver cirrhosis: a randomized controlled clinical trial comparing two diets with different sodium content", Liver, 13, pp.156~162 (1993)
25. Perez-Ayuso RM, "Randomized comparative study of efficacy of furosemide versus spironolactone in nonazotemic cirrhosis with ascites. Relationship between the diuretic response and the activity of the renin-aldosterone system", Gastroenterology, 84, pp.961~968 (1983)
26. Gatta A, "A pathophysiological interpretation of unresponsiveness to spironolactone in a stepped-care approach to the diuretic treatment of ascites in nonazotemic cirrhotic patients", Hepatology, 14, pp.231~236 (1991)
27. Reynolds TB, "Ascites", Clin Liver Dis, 4, pp.151~168 (2000)
28. Gerbes AL, "Medical treatment of ascites in cirrhosis", J Hepatol, 17(2), pp.4~9 (1993)
29. Descos L, "Comparison of six treatments of ascites in patients with liver cirrhosis. A clinical trial.", Hepatogastroenterology, 30, pp.15~20 (1983)
30. Gauthier A, "Salt or no salt in the treatment of cirrhotic ascites: a randomised study", Gut, 27, pp.705~709 (1986)
31. Reynolds TB, "Advantages of treatment of ascites without sodium restriction and without complete removal of excess fluid", Gut, 19, pp.549~553 (1978)
32. Sherlock S, "Ascites", pp.127~146 (2002), Blackwell Science
33. Wilkinson SP, "Renal sodium retention in cirrhosis: relation to aldosterone and nephron site", Clin Sci (Lond), 56, pp.169~177 (1979)
34. Santos J, "Spironolactone alone or in combination with furosemide in the treatment of moderate ascites in nonazotemic cirrhosis. A randomized comparative study of efficacy and safety", J Hepatol, 39, pp.187~192 (2003)
35. Sungaila I, "Spironolactone pharmacokinetics and pharmacodynamics in patients with cirrhotic ascites", Gastroenterology, 102, pp.1680~1685 (1992)
36. Sandhu BS, "Management of ascites in cirrhosis", Clin Liver Dis, 9, pp.715~732 (2005)
37. Pockros PJ, "Rapid diuresis in patients with ascites from chronic liver disease: the importance of peripheral edema", Gastroenterology, 90, pp.1827~1833 (1986)
38. Gines P, "Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites. Results of a randomized study", Gastroenterology, 93, pp.234~241 (1987)
39. Sterns RH, "Severe symptomatic hyponatremia: treatment and outcome. A study of 64 cases", Ann Intern Med, 107, pp.656~664 (1987)
40. Angeli P, "Cirrhosis and muscle cramps: evidence of a causal relationship", Hepatology, 23, pp.264~273 (1996)
41. Salerno F, "Repeated paracentesis and i.v. albumin infusion to treat 'tense' ascites in cirrhotic patients. A safe alternative therapy", J Hepatol, 5, pp.102~108 (1987)
42. Sola R, "Total paracentesis with dextran 40 vs diuretics in the treatment of ascites in cirrhosis: a randomized controlled study", J Hepatol, 20, pp.282~288 (1994)
43. Cotrim HP, "Paracentesis associated to dextran-70 in the treatment of ascites in patients with chronic liver diseases: a randomized therapeutic study", Arq Gastroenterol, 31, pp.125~129 (1994)
44. Hagege H, "Treatment of ascites in patients with liver cirrhosis without neither hyponatremia nor renal insufficiency. Results of a randomized study comparing diuretics and punctures compensated by albumin", Gastroenterol Clin Biol, 16, pp.751~755 (1992)
45. Peltekian KM, "Cardiovascular, renal, and neurohumoral responses to single large-volume paracentesis in patients with cirrhosis and diuretic-resistant ascites", Am J Gastroenterol, 92, pp.394~399 (1997)
46. Fernandez-Esparrach G, "Diuretic requirements after therapeutic paracentesis in non-azotemic patients with cirrhosis. A randomized double-blind trial of spironolactone versus placebo", J Hepatol, 26, pp.614~620 (1997)
47. Gines P, "Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis", Gastroenterology, 94, pp.1493~1502 (1988)
48. Ruiz-del-Arbol L, "Paracentesis-induced circulatory dysfunction: mechanism and effect on hepatic hemodynamics in cirrhosis", Gastroenterology, 113, pp.579~586 (1997)
49. Gines A, "Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis", Gastroenterology, 111, pp.1002~1010 (1996)
50. Panos MZ, "Single, total paracentesis for tense ascites: sequential hemodynamic changes and right atrial size", Hepatology, 11, pp.662~667 (1990)
51. Pozzi M, "Time course of circulatory and humoral effects of rapid total paracentesis in cirrhotic patients with tense, refractory ascites", Gastroenterology, 106, pp.709~719 (1994)
52. Rothschild MA, "Alterations in Albumin Metabolism after Serum and Albumin Infusions", J Clin Invest, 43, pp.1874~1880 (1964)
53. Wilkinson P, "The effect of repeated albumin infusions in patients with cirrhosis", Lancet, 2, pp.1125~1129 (1962)
54. Pietrangelo A, "Albumin gene expression is down-regulated by albumin or macromolecule infusion in the rat", J Clin Invest, 89, pp.1755~1760 (1992)
55. Arroyo V, "Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club", Hepatology, 23, pp.164~176 (1996)
56. Bories P, "The treatment of refractory ascites by the LeVeen shunt. A multi-centre controlled trial (57 patients)", J Hepatol, 3(21), pp.2~218 (1986)
57. Boyer TD, "Effect of indomethacin and prostaglandin A1 on renal function and plasma renin activity in alcoholic liver disease", Gastroenterology, 77, pp.215~222 (1979)
58. Mirouze D, "Effect of inhibitors of prostaglandin synthesis on induced diuresis in cirrhosis", Hepatology, 3, pp.50~55 (1983)
59. Gines P, "Paracentesis with intravenous infusion of albumin as compared with peritoneovenous shunting in cirrhosis with refractory ascites", N Engl J Med, 325, pp.829~835 (1991)
60. Wong F, "Transjugular intrahepatic portosystemic stent shunt: effects on hemodynamics and sodium homeostasis in cirrhosis and refractory ascites", Ann Intern Med, 122, pp.816~822 (1995)
61. Ochs A, "The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites", N Engl J Med, 332, pp.1192~1197 (1995)
62. Shiffman ML, "The role of transjugular intrahepatic portosystemic shunt for treatment of portal hypertension and its complications: a conference sponsored by the National Digestive Diseases Advisory Board", Hepatology, 22, pp.1591~1597 (1995)
63. Lind CD, "Incidence of shunt occlusion or stenosis following transjugular intrahepatic portosystemic shunt placement", Gastroenterology, 106, pp.1277~1283 (1994)
64. Russo MW, "Transjugular intrahepatic portosystemic shunt for refractory ascites: an analysis of the literature on efficacy, morbidity, and mortality", Am J Gastroenterol, 98, pp.2521~2527 (2003)
65. ter Borg PC, "Transjugular intrahepatic portosystemic shunts: long-term patency and clinical results in a patient cohort observed for 3-9 years", Radiology, 231통권 : 537, pp.537~545 (2004)
66. Kochar N, "Transjugular intrahepatic portosystemic stent shunt (TIPSS) modification in the management of post-TIPSS refractory hepatic encephalopathy", Gut, 55, pp.1617~1623 (2006)
67. Garcia-Tsao G, "The transjugular intrahepatic portosystemic shunt for the management of cirrhotic refractory ascites", Nat Clin Pract Gastroenterol Hepatol, 3, pp.380~389 (2006)
68. Huonker M, "Cardiac function and haemodynamics in alcoholic cirrhosis and effects of the transjugular intrahepatic portosystemic stent shunt", Gut, 44, pp.743~748 (1999)
69. Lebrec D, "Transjugular intrahepatic portosystemic shunts: comparison with paracentesis in patients with cirrhosis and refractory ascites: a randomized trial. French Group of Clinicians and a Group of Biologists", J Hepatol, 25, pp.135~144 (1996)
70. Gines P, "Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis", Gastroenterology, 123, pp.1839~1847 (2002)
71. Sanyal AJ, "Kowdley KV, Benner K, McCashland T. The North American Study for the Treatment of Refractory Ascites", Gastroenterology, 124, pp.634~636 (2003)
72. Fernandez J, "Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis", Hepatology, 35, pp.140~148 (2002)
73. Singh N, "Changing epidemiology and predictors of mortality in patients with spontaneous bacterial peritonitis at a liver transplant unit", Clin Microbiol Infect, 9, pp.531~537 (2003)
74. Garcia-Tsao G, "Spontaneous bacterial peritonitis", Gastroenterol Clin North Am, 21, pp.257~275 (1992)
75. Wu SS, "Ascitic fluid carcinoembryonic antigen and alkaline phosphatase levels for the differentiation of primary from secondary bacterial peritonitis with intestinal perforation", J Hepatol, 34, pp.215~221 (2001)
76. Felisart J, "Cefotaxime is more effective than is ampicillin-tobramycin in cirrhotics with severe infections", Hepatology, 5, pp.457~462 (1985)
77. Runyon BA, "Short-course versus long-course antibiotic treatment of spontaneous bacterial peritonitis. A randomized controlled study of 100 patients", Gastroenterology, 100, pp.1737~1742 (1991)
78. Rimola A, "Two different dosages of cefotaxime in the treatment of spontaneous bacterial peritonitis in cirrhosis: results of a prospective, randomized, multicenter study", Hepatology, 21, pp.674~679 (1995)
79. Mercader J, "Valdes M. Use of ceftriaxone in the treatment of bacterial infections in cirrhotic patients", Chemotherapy, 35, pp.23~26 (1999)
80. Sort P, "Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis", N Engl J Med, 341, pp.403~409 (1999)
81. Follo A, "Renal impairment after spontaneous bacterial peritonitis in cirrhosis: incidence, clinical course, predictive factors and prognosis", Hepatology, 20, pp.1495~1501 (1994)
82. Ho H, "A prospective controlled study of the risk of bacteremia in emergency sclerotherapy of esophageal varices", Gastroenterology, 101, pp.1642~1648 (1991)

관련 논문AI추천